<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Design for results: statistical software to optimize your clinical development strategy

 

Design for Results: Statistical Software to Optimize your Clinical Development Strategy, led by Yannis Jemiai, Ph.D., Chief Scientific Officer at Cytel. 

Good decisions are based on data, but with the profusion of data available in the life sciences today, analytics and design of experiment principles have never been more critical. Product development teams wanting to optimize decision-making should integrate quantitative modeling approaches in their study strategy and planning. Now more than ever, innovative trial design can play a key role in increasing success rates and accelerating medicines to market.

In this webinar Yannis Jemiai will discuss:

  • Both long-standing and new digital solutions that empower statisticians to advocate for these novel methods with the broader team
  • How quantitative sciences play a critical role in a product team’s ability to make optimal decisions earning the statistician a place at the strategic development table
  • How long-standing industry standard software East helps statisticians quickly and easily explore adaptation options for their study design
  • How Solara®, a first-in-class platform for clinical trial strategy, allows development teams to understand strategic priorities, explore more nuanced facets of trial design, and harmonize statistical and clinical perspectives to produce truly data-driven trials.

Download Slides

 

Yannis Jemiai

Yannis is an experienced statistician. Over the course of 15 years, Yannis has led the development of Cytel’s software and strategic consulting offerings. In his current role as CSO, Yannis has oversight of the corporate-level scientific agenda. This includes research portfolios in complex and innovative clinical trial designs, Bayesian methods, platform trials and master protocols, and advanced uses of real-world evidence to strengthen regulatory submissions. Yannis research interests include causal inference, adaptive trial design, financial and clinical strategy, statistical computing and regulatory affairs.

Yannis also sets the vision and guides the development of Cytel’s software products, ensuring that Cytel’s prolific scientific innovations are rapidly made available to clients. This includes Solara TM, a trial strategy platform for teams to confidently align on the right design, as well as industry leading statistical design packages East and Compass, and exact statistics applications StatXact and LogXact.

Yannis’s research has been published in numerous statistical journals. He earned his Ph.D. in Biostatistics from Harvard University, an M.P.H. from Columbia University, and a B.A. in Molecular and Cellular Biology also from Harvard.

Contact Us

Fill in the form below to get in touch